businesspress24.com - Europe Situation Forecasts Change - Report Highlights Ford Motor Company and Human Genome Sciences
 

Europe Situation Forecasts Change - Report Highlights Ford Motor Company and Human Genome Sciences

ID: 1055177

(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 11/09/11 -- Today, announced new reports highlighting Ford Motor Company (NYSE: F) and Human Genome Sciences (NASDAQ: HGSI). Gain market insight with full analysis and research downloads available at .

With the European Financial Stability Facility set to increase to $1.4 trillion, it marks a significant move forward to strengthen the safety net in place for Europe's most troubled countries. Private bondholders of Greek debt are settling at a 50% haircut as another $180 billion in fresh aid is set to arrive, enabling banks to recapitalize at a healthy 9% reserve. Overall, these measures will bring Greece's debt burden down to 120% of GDP by 2020. An important consideration is political commitment to this road map. Currently the global community appears to be on point with ECB's initiative, an outlook that should be sufficient to support markets around current levels.

Brighton Markets is releasing new coverage on Ford Motor Company for its current position within the consumer goods industry. Ford Motor Company (Ford) is a producer of cars and trucks. Ford and its subsidiaries are also engaged in other businesses, including financing vehicles. It operates under two segments: Automotive and Financial Services. Automotive segment includes the operations of Ford North America, Ford South America, Ford Europe and Ford Asia Pacific Africa. The full research report on Ford Motor Company (NYSE: F) is available here: .

Brighton Markets has released research on Human Genome Sciences for its changing role within the healthcare industry. Human Genome Sciences, Inc. (HGS) is a biopharmaceutical company. The Company's products are BENLYSTA (belimumab) for systemic lupus erythematosus (SLE) and raxibacumab for inhalation anthrax. GlaxoSmithKline (GSK) is a HGS partner in the co-development and commercialization of BENLYSTA. The full research report on Human Genome Sciences (NASDAQ: HGSI) is available here: .

About Brighton Markets




Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.



Contact:

Jean Barnes


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  PRA Wins Market Considerations in Europe Outlook - Featured Research on Citigroup Inc. and Johnson & Johnson
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 09.11.2011 - 08:00 Uhr
Sprache: Deutsch
News-ID 1055177
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

NEW YORK, NY


Phone:

Kategorie:

Commercial & Investment Banking


Anmerkungen:


Diese Pressemitteilung wurde bisher 48 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Europe Situation Forecasts Change - Report Highlights Ford Motor Company and Human Genome Sciences
"
steht unter der journalistisch-redaktionellen Verantwortung von

Brighton Markets (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Brighton Markets



 

Who is online

All members: 10 591
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 330


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.